238.56

0.09% -0.21

Handel nachbörslich: 238.58 0.02 +0.01%

Labcorp Holdings Inc (LH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt LH? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$238.77

Offen:

$239.33

24-Stunden-Volumen:

652.04K

Relative Volume:

1.14

Marktkapitalisierung:

$19.95B

Einnahmen:

$12.71B

Nettoeinkommen (Verlust:

$435.50M

KGV:

46.32

EPS:

5.15

Netto-Cashflow:

$843.20M

1W Leistung:

+2.83%

1M Leistung:

+3.30%

6M Leistung:

+10.56%

1J Leistung:

+6.98%

1-Tages-Spanne:

$236.95

$242.74

1-Wochen-Bereich:

$229.16

$242.74

52-Wochen-Spanne:

$191.97

$247.99

Labcorp Holdings Inc Stock (LH) Company Profile

Firmenname

Labcorp Holdings Inc

Sektor

Healthcare (1174)

Branche

Diagnostics & Research (58)

Telefon

(336) 229-1127

Adresse

358 S MAIN ST, BURLINGTON, NC

Mitarbeiter

67,000

Twitter

@labcorp

Nächster Verdiensttermin

2024-10-24

Neueste SEC-Einreichungen

LH's Discussions on Twitter

Vergleichen Sie LH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LH Labcorp Holdings Inc	238.56	19.95B	12.71B	435.50M	843.20M	5.15
TMO Thermo Fisher Scientific Inc	559.65	214.07B	42.37B	6.14B	7.78B	15.95
DHR Danaher Corp	238.36	172.16B	23.74B	3.89B	4.98B	5.24
A Agilent Technologies Inc	147.36	42.09B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	197.36	35.82B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	419.26	34.33B	3.84B	866.24M	792.60M	10.37

Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-07	Hochstufung	Evercore ISI	In-line → Outperform
2024-12-10	Fortgesetzt	Jefferies	Buy
2024-10-30	Hochstufung	HSBC Securities	Hold → Buy
2024-10-01	Eingeleitet	Piper Sandler	Neutral
2024-03-25	Hochstufung	Argus	Hold → Buy
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2024-02-09	Eingeleitet	Evercore ISI	In-line
2024-01-03	Eingeleitet	Barclays	Equal Weight
2023-09-06	Eingeleitet	HSBC Securities	Hold
2022-12-12	Herabstufung	Citigroup	Buy → Neutral
2022-09-19	Herabstufung	Argus	Buy → Hold
2022-08-22	Fortgesetzt	Morgan Stanley	Overweight
2022-01-28	Herabstufung	Deutsche Bank	Buy → Hold
2021-01-11	Hochstufung	Argus	Hold → Buy
2021-01-11	Herabstufung	Wolfe Research	Peer Perform → Underperform
2021-01-08	Herabstufung	Wolfe Research	Outperform → Peer Perform
2020-07-14	Hochstufung	BofA Securities	Neutral → Buy
2020-07-13	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-06-02	Fortgesetzt	Deutsche Bank	Buy
2020-05-15	Hochstufung	Mizuho	Neutral → Buy
2020-04-29	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2020-04-27	Hochstufung	Citigroup	Neutral → Buy
2020-04-27	Hochstufung	Wolfe Research	Underperform → Peer Perform
2020-01-08	Eingeleitet	Wells Fargo	Overweight
2019-07-16	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-06-21	Hochstufung	Deutsche Bank	Hold → Buy
2019-04-02	Hochstufung	Jefferies	Hold → Buy
2019-01-17	Eingeleitet	UBS	Buy
2019-01-03	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-12-03	Herabstufung	Craig Hallum	Buy → Hold
2018-10-30	Herabstufung	Argus	Buy → Hold
2018-10-25	Herabstufung	Canaccord Genuity	Buy → Hold
2018-10-19	Fortgesetzt	BofA/Merrill	Buy
2018-06-07	Hochstufung	KeyBanc Capital Mkts	Sector Weight → Overweight
2018-05-01	Hochstufung	Robert W. Baird	Neutral → Outperform
2018-03-23	Eingeleitet	Argus	Buy

Alle ansehen

Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten

09:35 AM

Why Labcorp (LH) is Poised to Beat Earnings Estimates Again - MSN

09:35 AM

Jan 15, 2025

Labcorp Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch

Jan 15, 2025

Labcorp to Provide Testing Device for Eli Lilly-Sponsored Lung Cancer Testing Program - Marketscreener.com

Jan 15, 2025

Jan 14, 2025

Is Labcorp Holdings Stock Underperforming the S&P 500? - MSN

Jan 14, 2025

Clinical Trials Support Services Market Poised for Notable Expansion by 2030, Driven by Substantial Investments in R&D from Pharmaceutical and Biopharmaceutical Companies - GlobeNewswire Inc.

Jan 14, 2025

Jan 13, 2025

Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 13, 2025

Jan 12, 2025

Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - Simply Wall St

Jan 12, 2025

Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - Yahoo Finance

Jan 12, 2025

Jan 10, 2025

Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Jan 10, 2025

Labcorp to Participate in J.P. Morgan Healthcare Conference - TipRanks

Jan 10, 2025

Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times

Jan 10, 2025

Labcorp Declares Quarterly Cash Dividend for 2025 - TipRanks

Jan 10, 2025

Jan 09, 2025

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025 - The Malaysian Reserve

Jan 09, 2025

Jan 08, 2025